Showing results (361-370 of 372) with videos related to
Sort By:
Pageof 38
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2011
Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trialF Egberts, R Gutzmer, S Ugurel, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 1, 2023
Early disease intervention with guselkumab in psoriasis leads to a higher rate of stable complete skin clearance ('clinical super response'): Week 28 results from the ongoing phase IIIb randomized, double-blind, parallel-group, GUIDE studyK Schäkel, K Reich, K Asadullah, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 29, 2017
Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT studyJ T Lear, M R Migden, K D Lewis, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC studyD Schadendorf, M M Amonkar, M Milhem, et al.British Journal of Cancer|July 14, 2011
A randomised, phase II study of intetumumab, an anti-αv-integrin mAb, alone and with dacarbazine in stage IV melanomaS O'Day, A Pavlick, C Loquai, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2014
Differential influence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efficacy in melanomaB Schilling, W Sondermann, F Zhao, et al.Blood|July 1, 1997
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of CancerR Willemze, H Kerl, W Sterry, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|November 5, 2005
Review of the potential photo-cocarcinogenicity of topical calcineurin inhibitors: position statement of the European Dermatology ForumJ Ring, J Barker, H Behrendt, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2006
Recommendations for the use of etanercept in psoriasis: a European dermatology expert group consensusW-H Boehncke, R A Brasie, J Barker, et al.Archives of Dermatological Research|February 22, 2012
German S3-guidelines on the treatment of psoriasis vulgaris (short version)A Nast, W H Boehncke, U Mrowietz, et al.Pageof 38